Novartis Ag (NVS) Intangibles (2009 - 2026)
Novartis Ag's (NVS) quarterly Intangibles came in at $42.1 billion in Q2 2026, up 43.89% year-over-year from $29.2 billion in Q2 2025, and up 4.64% quarter-over-quarter from $40.2 billion in Q1 2026.
Analysis
Novartis Ag (NVS) Intangibles (2009 - 2026) Analysis & Trends
Novartis Ag has disclosed Intangibles across 18 years of filings, most recently posting $42.1 billion for Q2 2026.
- In Q2 2026, Intangibles rose 43.89% year-over-year to $42.1 billion; the TTM figure through Jun 2026 stood at $42.1 billion (up 43.89% YoY), while the FY2025 annual figure was $29.4 billion, up 9.27% from the prior year.
- Intangibles came in at $42.1 billion for Q2 2026 at Novartis Ag, up from $40.2 billion in the prior quarter.
- In the past five years, Intangibles ranged from a high of $42.1 billion in Q2 2026 to a low of $1.6 billion in Q1 2023.
- Average Intangibles over 5 years is $28.9 billion, with a median of $28.5 billion recorded in 2023.
- Year-over-year, Intangibles plunged 95.54% in 2023 and jumped 1591.69% in 2024.
- Over 5 years, Intangibles stood at $31.6 billion in 2022, then decreased by 15.06% to $26.9 billion in 2023, then rose by 0.13% to $26.9 billion in 2024, then advanced by 9.27% to $29.4 billion in 2025, then soared by 43.06% to $42.1 billion in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $42.1 billion in Q2 2026, $40.2 billion in Q1 2026, and $29.4 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 47.05 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 17.39 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 30.64 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 63.28 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 60.96 Mn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 103.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.07 Bn |
| Mar 31, 2026 | 40.21 Bn |
| Dec 31, 2025 | 29.41 Bn |
| Sep 30, 2025 | 29.04 Bn |
| Jun 30, 2025 | 29.24 Bn |
| Mar 31, 2025 | 27.48 Bn |
| Dec 31, 2024 | 26.92 Bn |
| Sep 30, 2024 | 27.90 Bn |
| Jun 30, 2024 | 27.78 Bn |
| Mar 31, 2024 | 26.27 Bn |
| Dec 31, 2023 | 26.88 Bn |
| Sep 30, 2023 | 26.42 Bn |
| Jun 30, 2023 | 28.00 Bn |
| Mar 31, 2023 | 1.55 Bn |
| Dec 31, 2022 | 31.64 Bn |
| Sep 30, 2022 | 31.89 Bn |
| Jun 30, 2022 | 33.37 Bn |
| Mar 31, 2022 | 34.85 Bn |
| Dec 31, 2021 | 34.18 Bn |
| Sep 30, 2021 | 33.95 Bn |